Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.
Michael XiangElizabeth A KiddPublished in: Journal of gynecologic oncology (2019)
High-risk, early-stage endometrioid carcinoma is a heterogeneous population. BT was associated with a survival benefit in stage IB grade 3, whereas regional treatment with EBRT and lymphadenectomy was associated with a survival benefit in stage II grade 3.